SaliMark™ OSCC: Oral Cancer Salivary Diagnostic Test
A risk stratification test recommended for use by the clinician when suspicious lesions are observed and additional testing is warranted. These discriminatory salivary biomarkers have been clinically-validated in multiple large trials including studies in collaboration with the National Cancer Institute and with premiere US academic medical centers such as the University of Michigan, Michigan State University and the Providence Health System in Detroit. |
For more information about the SaliMark™ OSCC Test please visit the PeriRx website.